A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ceritinib Impurity 7 | CAS 112108-73-3 - Request Quote

Picture of Ceritinib Impurity 7

Ceritinib Impurity 7

SZ CAT No:SZ-C136008
CAS No
112108-73-3
Mol.F.
C7H5ClFNO2
Mol.Wt.
189.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Ceritinib Impurity 7 is chemically 1-Chloro-5-fluoro-2-methyl-4-nitrobenzene. Ceritinib Impurity 7 is supplied with detailed characterization data compliant with regulatory guideline. Ceritinib Impurity 7 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ceritinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 112108-73-3

Purchase 112108-73-3

Order 112108-73-3

Enquire 112108-73-3

price of 112108-73-3

112108-73-3 Supplier

112108-73-3 Manufacturer

112108-73-3 Exporter

buy high quality Ceritinib Impurity 7

Purchase Ceritinib Impurity 7

Ceritinib Impurity 7 suppliers

Ceritinib Impurity 7 manufacturers

Ceritinib Impurity 7 price

Order Ceritinib Impurity 7

Enquire Ceritinib Impurity 7

Ceritinib Impurity 7 cost

Ceritinib Impurity 7 Supplier

Ceritinib Impurity 7 Distributor

Ceritinib Impurity 7 for Method Validation

Ceritinib Reference Standard

Ceritinib Impurity 7 for ANDA Filing

Ceritinib Impurity 7 for Forced Degradation Studies

Ceritinib Impurity 7 Identification Standards

Ceritinib Impurity 7 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,